Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. PANACEA BIOTECH GENNEX LAB./
PANACEA BIOTECH
 
P/E (TTM) x 35.0 -60.9 - View Chart
P/BV x 4.5 0.9 511.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GENNEX LAB.   PANACEA BIOTECH
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
PANACEA BIOTECH
Mar-23
GENNEX LAB./
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs9191 4.8%   
Low Rs5107 4.5%   
Sales per share (Unadj.) Rs3.475.1 4.5%  
Earnings per share (Unadj.) Rs0.3-5.5 -5.1%  
Cash flow per share (Unadj.) Rs0.30.9 37.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs4.5137.7 3.3%  
Shares outstanding (eoy) m176.6461.25 288.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.12.0 104.2%   
Avg P/E ratio x25.0-27.1 -92.2%  
P/CF ratio (eoy) x21.0170.0 12.4%  
Price / Book Value ratio x1.51.1 141.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,2299,142 13.4%   
No. of employees `000NANA-   
Total wages/salary Rs m791,265 6.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5934,599 12.9%  
Other income Rs m40517 7.7%   
Total revenues Rs m6335,116 12.4%   
Gross profit Rs m4747 99.8%  
Depreciation Rs m9391 2.3%   
Interest Rs m1444 30.5%   
Profit before tax Rs m64128 49.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15466 3.1%   
Profit after tax Rs m49-337 -14.6%  
Gross profit margin %7.91.0 773.5%  
Effective tax rate %22.8363.5 6.3%   
Net profit margin %8.3-7.3 -113.0%  
BALANCE SHEET DATA
Current assets Rs m4875,623 8.7%   
Current liabilities Rs m2953,297 9.0%   
Net working cap to sales %32.350.6 63.9%  
Current ratio x1.61.7 96.7%  
Inventory Days Days459 6.9%  
Debtors Days Days57,912,58948 121,442,388.6%  
Net fixed assets Rs m8357,028 11.9%   
Share capital Rs m18061 294.2%   
"Free" reserves Rs m6238,375 7.4%   
Net worth Rs m8048,436 9.5%   
Long term debt Rs m163202 80.8%   
Total assets Rs m1,32212,712 10.4%  
Interest coverage x5.73.9 146.9%   
Debt to equity ratio x0.20 848.1%  
Sales to assets ratio x0.40.4 124.1%   
Return on assets %4.7-2.3 -205.9%  
Return on equity %6.1-4.0 -153.1%  
Return on capital %8.02.0 400.6%  
Exports to sales %42.143.3 97.3%   
Imports to sales %13.624.4 55.6%   
Exports (fob) Rs m2501,992 12.6%   
Imports (cif) Rs m811,124 7.2%   
Fx inflow Rs m2501,992 12.6%   
Fx outflow Rs m861,191 7.2%   
Net fx Rs m164801 20.4%   
CASH FLOW
From Operations Rs m237-4,225 -5.6%  
From Investments Rs m-3834,303 -8.9%  
From Financial Activity Rs m210-184 -114.5%  
Net Cashflow Rs m64-105 -60.8%  

Share Holding

Indian Promoters % 23.6 73.6 32.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.0 -  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 26.4 289.3%  
Shareholders   69,723 47,091 148.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs Panacea Biotech Share Price Performance

Period GENNEX LABORATORIES Panacea Biotech S&P BSE HEALTHCARE
1-Day 1.35% -1.74% 1.18%
1-Month -13.90% -20.01% -0.75%
1-Year 189.91% 11.75% 61.82%
3-Year CAGR 62.78% -12.26% 18.16%
5-Year CAGR 40.09% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.